Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PPARG | P37231 | 5/20 | 0.84 |
| ▸ | PPARD | Q03181 | 5/20 | 0.84 |
| ▸ | PPARA | Q07869 | 5/20 | 0.84 |
| ▸ | F7 | P08709 | 5/20 | 0.84 |
| ▸ | F3 | P13726 | 5/20 | 0.84 |
| ▸ | TERT | O14746 | 3/20 | 0.84 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.84 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.84 |
| ▸ | FABP4 | P15090 | 3/20 | 0.84 |
| ▸ | TOP1 | P11387 | 3/20 | 0.84 |
| ▸ | MAPT | P10636 | 2/20 | 0.84 |
| ▸ | BLM | P54132 | 2/20 | 0.84 |
| ▸ | LMNA | P02545 | 2/20 | 0.84 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.84 |
| ▸ | DUSP3 | P51452 | 2/20 | 0.84 |
| ▸ | CYP19A1 | P11511 | 2/20 | 0.84 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.84 |
| ▸ | NR4A2 | P43354 | 2/20 | 0.84 |
| ▸ | SIRT6 | Q8N6T7 | 2/20 | 0.84 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.84 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2855222 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2573063 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2574228 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2858103 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL552081 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2575442 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL17048016 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL808536 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL10201666 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 | |
| SCHEMBL2574226 | 1.00 | PPARG (0.84) | PPARGPPARDPPARAF7F3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 27 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12522686-B2 | Method for producing hydroxy-fatty-acid-based polyols | U. WINDMÖLLER INNOVATION GMBH & CO. KG (DE) | 2026-01-13 | — | — | US | disclosed |
| CN-120053660-A | Hydrophilic complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-120053661-A | Hydrophilic fatty acid complex for preventing, preventing or treating microbial infection, preparation and application thereof | 太阳雨林(北京)生物医药有限公司 | 2025-05-30 | — | — | CN | disclosed |
| CN-119855607-A | Carbon chain substance for regulating transmembrane transport and fluidity of cell membrane, preparation and application | 太阳雨林(北京)生物医药有限公司 | 2025-04-18 | — | — | CN | disclosed |
| EP-4150103-B1 | METHOD FOR MANUFACTURING HYDROXY FATTY ACID-BASED POLYOLS | U WINDMOELLER INNOVATION GMBH & CO KG (DE) | 2025-04-09 | — | — | EP | disclosed |
| EP-4520348-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | Sunforest (Beijing) Biopharma Ltd (CN) | 2025-03-12 | — | — | EP | disclosed |
| WO-2023213310-A9 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2025-02-20 | — | — | WO | disclosed |
| US-11951077-B2 | Stabilized menthol and other volatile compound compositions and methods | GHALILI BABAK (US) | 2024-04-09 | — | — | US | disclosed |
| WO-2023213310-A1 | CARBON CHAIN SUBSTANCE FOR REGULATING TRANSMEMBRANE TRANSPORT AND FLUIDITY OF CELL MEMBRANES, AND PREPARATION AND USE THEREOF | 太阳雨林(北京)生物医药有限公司 | 2023-11-09 | — | — | WO | disclosed |
| US-20230312805-A1 | METHOD FOR PRODUCING HYDROXY-FATTY-ACID-BASED POLYOLS | UNIVERSITÄT BIELEFELD (DE) | 2023-10-05 | — | — | US | disclosed |
| EP-2970169-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | Elevance Renewable Sciences, Inc. (US) | 2016-01-20 | — | — | EP | disclosed |
| US-20150307438-A1 | Methods of Making Organic Compounds by Metathesis | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| US-20150307469-A1 | Glycitan Esters of Unsaturated Fatty Acids and Their Preparation | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-10-29 | — | — | US | disclosed |
| US-9120742-B2 | Methods of making organic compounds by metathesis | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2015-09-01 | — | — | US | disclosed |
| US-9045447-B2 | Glycitan esters of unsaturated fatty acids and their preparation | Elevance Renewable Sicences, Inc. (US) | 2015-06-02 | — | — | US | disclosed |
| WO-2014159226-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| US-20140275580-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2014-09-18 | — | — | US | disclosed |
| EP-2121546-A2 | METHODS OF MAKING ALPHA, OMEGA-DICARBOXYLIC ACID ALKENE DERIVATIVES BY METATHESIS | Elevance Renewable Sciences, Inc. (US) | 2009-11-25 | — | — | EP | disclosed |
| US-20090264672-A1 | METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2009-10-22 | — | — | US | disclosed |
| WO-2008140468-A2 | METHODS OF MAKING α, ω -DICARBOXYLIC ACID ALKENE DERIVATIVES BY METATHESIS | ELEVANCE RENEWABLE SCIENCES, INC. (US) | 2008-11-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140275580-A1 | GLYCITAN ESTERS OF UNSATURATED FATTY ACIDS AND THEIR PREPARATION | SGMS1, SCD5, FADS1 | PPARG 64/4885PPARD 369/4885PPARA 247/4885 |
| US-20090264672-A1 | METHODS OF MAKING ORGANIC COMPOUNDS BY METATHESIS | COASY, FASN, HAO2 | PPARG 1388/4885PPARD 352/4885PPARA 879/4885 |
| US-11951077-B2 | Stabilized menthol and other volatile compound compositions and methods | DHCR24, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, DHCR7 | PPARG 1445/4885PPARD 1132/4885PPARA 1933/4885 |
| US-20150307469-A1 | Glycitan Esters of Unsaturated Fatty Acids and Their Preparation | SGMS1, SCD5, FADS1 | PPARG 64/4885PPARD 369/4885PPARA 247/4885 |
| US-20150307438-A1 | Methods of Making Organic Compounds by Metathesis | COASY, FASN, HAO2 | PPARG 1388/4885PPARD 352/4885PPARA 879/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.